Related Experiment Video
Updated: May 30, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Deregulation of microRNAs in myelodysplastic syndrome
G W Rhyasen1, D T Starczynowski
1Department of Cancer and Cell Biology, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Abstract:
Myelodysplastic syndromes (MDSs) consist of a family of hematopoietic stem cell (HSC) disorders characterized by ineffective differentiation of hematopoietic progenitors, bone marrow dysplasia, genetic instability and a propensity to develop acute myeloid leukemia. The development of MDS is poorly understood and therefore, effective treatment options are limited. Recent progress has been made in identifying altered signaling pathways and understanding the HSC defects, which are thought to contribute to the pathogenesis of MDS. Several of these findings have implicated aberrant expression and function of microRNAs (miRNAs). Unique miRNA expression patterns have been identified in MDS patients and modeled in mice to recapitulate features of MDS. Here, we review miRNA expression profiles identified in MDS patients, and describe the association of miRNA expression with MDS subtypes and disease outcome, clinical implications of miRNAs in MDS and deregulation of miRNAs in mouse model systems of MDS.
Insights
MicroRNAs (miRNAs) show unique expression patterns in myelodysplastic syndromes (MDS), impacting disease subtypes and outcomes. Understanding miRNA roles offers potential for novel MDS diagnostics and therapeutics.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Myelodysplastic syndromes (MDS) are stem cell disorders with poor differentiation and high leukemia risk.
- Current understanding of MDS pathogenesis and effective treatments remain limited.
- Aberrant microRNA (miRNA) expression is increasingly implicated in MDS development.
Purpose of the Study:
- To review miRNA expression profiles in MDS patients.
- To associate miRNA expression with MDS subtypes and clinical outcomes.
- To explore the role of miRNA deregulation in MDS mouse models.
Main Methods:
- Review of published miRNA expression profiles in MDS.
- Analysis of associations between miRNA patterns, MDS subtypes, and prognosis.
- Examination of miRNA deregulation in preclinical MDS models.
Main Results:
- Distinct miRNA expression signatures identified in MDS patients.
- Specific miRNA patterns correlate with MDS subtypes and patient outcomes.
- Mouse models demonstrate recapitulation of MDS features due to miRNA dysregulation.
Conclusions:
- miRNAs are key players in MDS pathogenesis.
- miRNA profiling holds potential for MDS diagnosis and prognosis.
- Targeting miRNAs may offer new therapeutic strategies for MDS.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
06:33Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation